Chemicals · Fiscal year end Dec 31

Earth Corporation

4985

アース製薬株式会社

FIGI BBG000DVJ4J74985.T4985 JPCorp. no. 9010001009832

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-10

For the first half of the fiscal year to 2026-12: Revenue ¥109.1 billion (+6.2% YoY), Ordinary income ¥13.5 billion (-1.3% YoY), Net income ¥8.8 billion (-6.2% YoY).

	This period	Year on year
Revenue	¥109.1bn	+6.2%
Ordinary profit	¥13.5bn	-1.3%
Net profit to owners	¥8.8bn	-6.2%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4985/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2025-12-31

Revenue: ¥179.2bn
Net income: ¥5.2bn
ROE: 7.3%
Equity ratio: 50.2%
Dividend / share: ¥125
Employees: 4,963

Revenue · ¥bn

Net income · ¥bn

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2025-12-31	¥179.2bn	¥5.2bn	¥149.4bn	¥81.3bn	7.3%	¥240	¥10.8bn
2024-12-31	¥169.3bn	¥3.5bn	¥135.6bn	¥74.7bn	5.1%	¥158.26	¥14.0bn
2023-12-31	¥158.3bn	¥4.1bn	¥132.4bn	¥72.0bn	6.3%	¥185.57	¥7.5bn
2022-12-31	¥152.3bn	¥5.3bn	¥124.5bn	¥68.0bn	8.6%	¥240.47	¥3.9bn
2021-12-31	¥203.8bn	¥7.1bn	¥120.7bn	¥64.6bn	12.4%	¥323.76	¥4.8bn

Indicators

Computed by us from filings · fiscal year to 2025-12-31

Metric	Value	Percentile among listed companies
ROE, %	7.3	40.8
Ordinary margin	0.0496	37.8
Equity ratio, %	50.2	41.6
Revenue growth	0.0585	54.5
Net income growth	0.5073	75.4
Operating cash flow / assets	0.0723	56

Policy-uncertainty measure1.00 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Politics & geopolitics 2

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 2.8% held by other listed companies.

Results wording balance: +0.58. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥7.7bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥39m, 0.4% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/4985/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Internal control, 2026-03-24: see filing 上記の評価の結果、2025年12月31日現在における当社グループの財務報告に係る内部統制は有効であると判断しました。 Filing

Segments, votes and tender offers

Stated in EDINET filings

Segments: Household Products Business, General Sanitary Management. /v1/companies/4985/segments

Latest voting result: 2026-03-25 · 取締役9名選任の件 · passed. /v1/companies/4985/voting

Ownership changes

All companies →

2024-01-22

Below 5%−1.10pt

M&G Investment Management Limited cut holdings in Earth Corporation (4985) to 3.92% from 5.02%, below the 5% threshold.

S100SN3PFiler profile Original filing (PDF, Japanese)
2023-02-22

New 5% stake

M&G Investment Management Limited disclosed a 5.02% stake in Earth Corporation (4985), crossing the 5% reporting threshold.

S100Q9I3Filer profile Original filing (PDF, Japanese)

5% filings

Large shareholding reports on 4985

Filed	Filer	Stake	Change	Stated purpose
2024-01-22	M&G Investment Management Limited	3.92%	−1.10pt	pure investment
2023-02-22	M&G Investment Management Limited	5.02%	—	pure investment

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: 12 issues
Book value: ¥4.0bn
Sold in the year: — — issues
Bought in the year: — — issues
Mutual, both reports: 2
Held by listed cos.: 11

Holds	Book value	Shares vs. prior year	Mutual
MatsukiyoCocokara & Co 3088	¥2,115m	0.0%	both reports
FUJITA KANKO INC. 9722	¥611m	+400.0%	no
Chugin Financial Group, Inc. 5832	¥395m	0.0%	both reports
TAIKO PHARMACEUTICAL CO., LTD. 4574	¥390m	0.0%	no
OHKI HEALTHCARE HOLDINGS CO.,LTD. 3417	¥284m	0.0%	no
KOHNAN SHOJI CO.,LTD. 7516	¥80m	0.0%	no
DCM Holdings Co.,Ltd. 3050	¥21m	—	no
PLANET,INC. 2391	¥15m	0.0%	no
AEON Co.,Ltd. 8267	¥14m	+200.0%	no
KUSURI NO AOKI HOLDINGS CO., LTD. 3549	¥14m	0.0%	no

Held by: Chugin Financial Group, Inc. 5832, MatsukiyoCocokara & Co 3088, Toyo Seikan Group Holdings, Ltd. 5901, HOKKAN LIMITED 5902, T.HASEGAWA CO.,LTD. 4958, SEKICHU CO.,LTD. 9976, KOBAYASHI PHARMACEUTICAL CO.,LTD. 4967, DENTSU GROUP INC. 4324, NICHIBAN CO., LTD 4218, LEC,INC. 7874, TAKASAGO INTERNATIONAL CORPORATION 4914

Purposes, all holdings and mutual flags via /v1/companies/4985/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31

Shareholder	Shares	Ratio
大塚製薬株式会社	2,200,000	10.06%
株式会社大塚製薬工場	1,948,000	8.91%
日本マスタートラスト信託銀行株式会社（信託口）	1,898,000	8.69%
アース製薬社員持株会	1,062,000	4.86%
大鵬薬品工業株式会社	600,000	2.74%
株式会社日本カストディ銀行（信託口）	450,000	2.06%
大塚化学株式会社	400,000	1.83%
株式会社中国銀行	340,000	1.55%
大塚エステート株式会社	239,000	1.09%
JP MORGAN CHASE BANK 385781	213,000	0.97%

U.S. funds holding 4985

SEC Form N-PORT, reports to 2026-07-31

46 U.S. funds held 967,126 shares worth $28.5m.

Fund	Shares	Value	% of fund	As of
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS	205,934	$6.1m	0.001%	2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS	156,535	$4.5m	0.001%	2026-06-30
iShares Core MSCI EAFE ETF iShares Trust	83,800	$2.5m	0.001%	2026-07-31
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS	56,643	$1.7m	0.012%	2026-07-31
iShares MSCI EAFE Small-Cap ETF iShares Trust	52,800	$1.6m	0.012%	2026-07-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4985
GET /v1/companies/4985/financials
GET /v1/companies/4985/details
GET /v1/companies/4985/segments
GET /v1/companies/4985/voting
GET /v1/companies/4985/tender-offers
GET /v1/companies/4985/indicators
GET /v1/companies/4985/earnings-releases
GET /v1/events?ticker=4985
GET /v1/companies/4985/trades         
GET /v1/companies/4985/cross-holdings 
GET /v1/companies/4985/brief

Plans from $9 a month · Documentation